On December 22, 2024, the 2024 Eastern International Interventional Medicine Expo (hereinafter referred to as the “Interventional Expo”) concluded successfully at the Shanghai World Expo Exhibition and Convention Center after several days of events. The expo saw the participation of eight academicians, including Academician Fan Daiming, Academician Ge Junbo, and Academician Liao Wanqing, along with 385 top domestic and international experts, scholars, and industry elites. Nearly 60 specialized forums and conferences on interventional medicine were held, showcasing the latest interventional medical technologies, promoting academic exchange, driving technological innovation, and fostering industrial development, thereby providing a platform for global professionals in the field of interventional medicine to collaborate and exchange ideas.
As a key highlight of the expo, the 2024 Top Ten Interventional New Technologies Release Ceremony was held concurrently. This event aimed to attract outstanding medical device innovation projects and talents from around the world by providing a high-level competitive platform, injecting new momentum into the sustainable development of the interventional medicine field. It sought to discover and nurture innovative and market-potential technologies, products, and services, thereby promoting the continuous and healthy development of the industry.
After rigorous evaluation by a panel of authoritative experts, CCRC MedTech was honored with the “2024 Top Ten Interventional New Technologies – Innovation Empowerment Award” for its exceptional and optimized clinical research strategies and highly innovative solutions. CCRC MedTech has played a pivotal role in the research, development, and clinical transformation of medical devices, providing critical support and empowerment for breakthroughs and advancements in the medical device industry.
In the process of medical device development and market launch, meeting clinical needs and ensuring product safety and efficacy are of utmost importance. These factors not only influence regulatory approvals but also directly impact patient health and safety. CCRC MedTech plays a vital role in this critical phase—assisting device manufacturers in designing and executing high-quality clinical trials, rigorously evaluating the safety and efficacy of medical devices with a scientific approach, and thereby accelerating the market launch of new products.
This prestigious award not only recognizes CCRC MedTech’s outstanding performance in the medical device CRO service sector but also affirms its ability to continuously innovate and deeply empower medical device enterprises. CCRC MedTech will continue to deepen its collaborations with top-tier domestic and international research institutions, exploring the boundless possibilities of medical device technology. We firmly believe that through relentless effort and innovation-driven strategies, CCRC MedTech will help bring more Chinese-originated research achievements to the global stage, delivering greater benefits to patients worldwide and contributing Chinese wisdom and solutions to the flourishing development of the global medical device and healthcare industry!
